Results 1 to 10 of about 194,359 (349)

Granulocyte colony-stimulating factor produces long-term changes in gene and microRNA expression profiles in CD34+ cells from healthy donors [PDF]

Haematologica, 2014
Granulocyte colony-stimulating factor is the most commonly used cytokine for the mobilization of hematopoietic progenitor cells from healthy donors for allogeneic stem cell transplantation. Although the administration of this cytokine is considered safe,
Alicia Báez, Beatriz Martín-Antonio, José I. Piruat, Concepción Prats, Isabel Álvarez-Laderas, M. Victoria Barbado, Magdalena Carmona, Álvaro Urbano-Ispizua, Jose Antonio Pérez-Simón   +8 more
doaj   +5 more sources

Anaplastic carcinoma of the pancreas producing granulocyte-colony stimulating factor: a case report [PDF]

Journal of Medical Case Reports, 2008
Introduction The granulocyte-colony stimulating factor-producing tumor was first reported in 1977, however, anaplastic pleomorphic type carcinoma of the pancreas producing granulocyte-colony stimulating factor is still rare.
Nakajima Atsushi, Takahashi Hirokazu, Inamori Masahiko, Abe Yasunobu, Kobayashi Noritoshi, Kubota Kensuke, Yamanaka Shoji   +6 more
doaj   +4 more sources

Granulocyte colony-stimulating factor and leukemogenesis [PDF]

Mediators of Inflammation, 2004
THE granulocyte colony-stimulating factor (G-CSF) plays an important role in normal granulopoiesis. Its functions are mediated by specific receptors on the surface of responsive cells and, upon ligand binding, several cytoplasmic tyrosine kinases are ...
Lorena Lobo de Figueiredo, Rodrigo Siqueira de Abreu e Lima, Eduardo Magalhães Rego   +2 more
doaj   +3 more sources

Successful Treatment of Granulocyte Colony‐Stimulating Factor‐Related Aortitis in Prostate Cancer [PDF]

IJU Case Reports
Introduction The frequency of granulocyte colony‐stimulating factor‐related aortitis is low. We report a case of successful corticosteroid treatment in a patient with prostate cancer who developed aortitis following pegfilgrastim administration.
Shota Yamada, Kota Amamoto, Nobuhide Maekawa, Kazusato Hara, Takahisa Iwata, Yushi Imasato, Tomohiro Matsuo, Masataka Furukawa, Ryoichi Imamura   +8 more
doaj   +2 more sources

Granulocyte colony stimulating factor promotes scarless tissue regeneration [PDF]

Cell Reports
Summary: Mammals typically heal with fibrotic scars, and treatments to regenerate human skin and hair without a scar remain elusive. We discovered that mice lacking C-X-C motif chemokine receptor 2 (CXCR2 knockout [KO]) displayed robust and complete ...
Jianhe Huang, Satish Sati, Christina Murphy, Casey A. Spencer, Emmanuel Rapp, Stephen M. Prouty, Scott Korte, Olivia Ahart, Emily Sheng, Parker Jones, Anna E. Kersh, Denis Leung, Thomas H. Leung   +12 more
doaj   +2 more sources

Granulocyte Colony-Stimulating-Factor-Producing Bladder Carcinoma: A Case Report and Literature Review. [PDF]

Cureus
Yamashita K, Yoshida K, Kubota S, Sakamoto T, Shiseki T, Uematsu H, Nakazawa T, Inui M.   +7 more
europepmc   +3 more sources

The effects of granulocyte-colony stimulating factor on chronic liver disease: a meta-analysis

Journal of Infection in Developing Countries, 2022
Introduction: The clinical application of granulocyte-colony stimulating factor on chronic liver disease is still controversial. The study aimed to evaluate the effects of granulocyte-colony stimulating factor on chronic liver disease. Methodology: A
Pei Shi, Jianguo Zhang, Min Wu, Ting Zheng, An Liang, Zhilong Wen, Xiaoping Wu   +6 more
doaj   +1 more source

Granulocyte colony‐stimulating factor associated arteritis in a patient with castration‐resistant prostate cancer

IJU Case Reports, 2022
Introduction Granulocyte colony‐stimulating factor‐associated arteritis is a rare adverse event of granulocyte colony‐stimulating factor, with an incidence of 0.47% among all patients who receive granulocyte colony‐stimulating factor. We herein present a
Satoshi Nitta, Takazo Tanaka, Ryota Yanagihashi, Haruna Nonaka, Shuhei Suzuki, Tomokazu Kimura, Shuya Kandori, Akio Hoshi, Hiromitsu Negoro, Hiroyuki Nishiyama   +9 more
doaj   +1 more source

Outcome and Cost-Effectiveness Analysis of Long-acting G-CSF as Primary Prophylaxis of Neutropenia Induced by Chemotherapy in Breast Cancer Patients, From a Retrospective Study

Cancer Control, 2023
Purpose This retrospective analysis aimed to evaluate the clinical outcomes and cost-effectiveness of long-acting granulocyte-colony stimulating factor as primary prophylaxis of neutropenia caused by chemotherapy for breast cancer.
Yaqin Wang PhD, Chenglong Zhao MA, Peizhi Ma MS, Dandan Jiang PhD   +3 more
doaj   +1 more source

Transient thrombocytopenia in a cat following G‐CSF treatment

Veterinary Medicine and Science, 2022
A 4‐year‐old, castrated male, Russian blue cat with idiopathic epilepsy was diagnosed with neutropenia. The neutropenia was classified as idiopathic after blood tests and abdominal imaging did not reveal an infectious, inflammatory or neoplastic ...
Kyeong‐Bo Kim, Ju‐Hyun An, Jeong‐Hwa Lee, Su‐Min Park, Hyung Kyu Chae, Woo‐Jin Song, Hwa‐Young Youn   +6 more
doaj   +1 more source